PIN40 - Cost Of Erythropoietin Use In The Early Access Program Of Telaprevir For The Treatment Of Metavir F3-F4 Patients With Genotype 1 Hcv In Brazil
| Autor: | Morais, A.D., Magno, L.A., Nogueira, C.V. |
|---|---|
| Zdroj: | In Value in Health May 2014 17(3):A272-A272 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect